Results 41 to 50 of about 78,703 (202)

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.

open access: yesPLoS ONE, 2022
BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle   +8 more
doaj   +1 more source

Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs [PDF]

open access: yes, 2017
Increases in prothrombin time (PT) and international normalised ratio (INR) characterise acute liver injury (ALI) and failure (ALF), yet a wide heterogeneity in clotting abnormalities exists.
A Clauss   +39 more
core   +4 more sources

Disseminated intravascular coagulation in dogs with gastric dilatation-volvulus syndrome

open access: yesVeterinární Medicína, 2013
Gastric dilatation and volvulus syndrome is associated with changes in haemostatic profiles. The aims of this study were to compare selected haemostatic and fibrinolytic parameters between healthy dogs and dogs with gastric dilatation and volvulus ...
I. Uhrikova   +4 more
doaj   +1 more source

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample. [PDF]

open access: yesPLoS ONE, 2015
A substantial fraction of all American healthcare expenditures are potentially wasted, and practices that are not evidence-based could contribute to such waste.
Manu N Capoor   +17 more
doaj   +1 more source

Spontaneous bleeding in a patient with malignant lymphoma: A case of acquired hemophilia [PDF]

open access: yes, 2000
Background: Acquired hemophilia is a rare condition which can be associated with lymphoproliferative disease. Case Report: Eleven yea rs after the diagnosis of immunocytoma had been made, a 72-year-old man developed a high-titer factor VIII inhibitor. At
Brack, N.   +5 more
core   +1 more source

PARTIAL THROMBOPLASTIN TIME CHANGES IN ASTHMA

open access: yesJournal of Research in Medical Sciences, 2003
Study objective: To exam the effect of asthma on- coagulation pathway. Methods: Case control study with 73 asthmatic pagtients at different age. Results: We show that PIT in asthmatic patients is longer than in control group (P < 0.0001). We
A MIRALAEI, F AFSHINNIA
doaj  

Green tea consumption effects on coagulation profile

open access: yesJournal of Applied Hematology, 2020
OBJECTIVES: The objective was to study the prothrombin time (PT) and activated partial thromboplastin time (APTT) values among Sudanese regularly drinking green tea. METHODS: This comparative study was conducted from May to November 2018 at the cities of
Ahmed Mohammed Elnour Elkhalifa   +9 more
doaj   +1 more source

The management of a blood donor bitten by a snake [PDF]

open access: yes, 2017
The worldwide burden of snakebite is high and venomous snakes are found in many regions of the world and are a threat to public health. In Italy, for instance, viper bites are an infrequent but not negligible event.
Catalano, Liviana   +5 more
core   +1 more source

Platelet inhibitory effects of the Phase 3 anticancer and normal tissue cytoprotective agent, RRx-001. [PDF]

open access: yes, 2018
The platelet inhibitory effects of the Phase 3 anticancer agent and nitric oxide (NO) donor, RRx-001, (1-bromoacetyl-3,3-dinitroazetidine) were examined ex vivo and compared with the diazeniumdiolate NO donor, diethylenetriamine NONOate (DETA-NONOate ...
Bryan Oronsky   +3 more
core   +1 more source

Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study [PDF]

open access: yes, 2001
We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked Fibrin) showed a strong and independent association with incident ischaemic heart disease (IHD) in the Caerphilly Study cohort of 1,998 men a-ed 49-65.
Lowe, G.D.O.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy